Chlamydia Screening in Women (CHL)
Line of business: Commercial and Medicaid Expansion
Measure Description
Members 16-24 who were identified as sexually active and had at least one test for chlamydia during the measurement year.
Notes
- This measure applies to members ages 16-24 years as of December 31st of the measurement year.
- Sexually active members are identified using two methods pharmacy claims and claim encounters.
Measure Compliance (numerator):
- Members who had at least one chlamydia test during the measurement year.
Best Practices
- Encourage parents to establish care with a PCP and educate parents on the importance of preventive care visits.
- Educate patients and their families or caregivers about the importance of routine screenings and medication compliance.
- Utilize reminders in the patient’s EMR to alert staff of when patients’ screenings are due.
- Promote signing up for patient portal if your facility provides it (i.e., MyChart).
- Remind patients of upcoming appointments by making phone calls, sending text messages or utilizing patient portal messaging.
- Perform chlamydia screening every year on every 16–24-year-old female identified as sexually active.
- Add chlamydia screening as a standard lab for women 16-24 years old.
- Utilize urine test for screening as an option for patients.
Exclusions
- Members in hospice during the measurement year.
- Members who die during the measurement year.
- Sex assigned male at birth.
- Members who had a pregnancy test during the measurement year and a prescription for isotretinoin OR an x-ray on the date of the pregnancy test through six days after the pregnancy test.
Coding Disclaimer
The analysis of any medical coding question related to a measure is dependent on the measure’s technical specifications including the factual situations present related to the member, the practice, the professionals, and the medical services provided.
Questions
Should you have specific coding or other questions related to the measure, please send your questions to BlueAlliance@bcbsnd.com.
NCQA Copyright Notice and Disclaimer
The HEDIS® measures and specifications were developed by and are owned by NCQA. The HEDIS measures and specifications are not clinical guidelines and do not establish a standard of medical care. NCQA makes no representations, warranties, or endorsement about the quality of any organization or physician that uses or reports performance measures and NCQA has no liability to anyone who relies on such measures and specifications. NCQA holds a copyright in these materials and can rescind or alter these materials at any time. These materials may not be modified by anyone other than NCQA. Use of the Rules for Allowable Adjustments of HEDIS to make permitted adjustments of the materials does not constitute a modification. Any commercial use and/or internal or external reproduction, distribution and publication must be approved by NCQA and are subject to a license at the discretion of NCQA. Any use of the materials to identify records or calculate measure results, for example, requires a custom license and may necessitate certification pursuant to NCQA’s Measure Certification Program. Reprinted with permission by NCQA. © [2025] NCQA, all rights reserved.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
Updated 7/16/2025
